Sanofi
Ipsen to acquire Sanofi assets in $88 million deal
February 13, 2017Sales and Marketing Boehringer Ingelheim, Prontalgine, Sanofi, ipsen
Ipsen has announced that it is set to enter into a definitive agreement to acquire five consumer healthcare products from …
Sanofi & Regeneron deflect Amgen’s legal marketing block on Praluent
February 9, 2017Manufacturing and Production, Sales and Marketing Amgen, Regeneron, Repatha, Sanofi, praluent
Sanofi and Regeneron have successfully won in a US Court ruling calling for the suspension of the permanent injunction of …
Sanofi reinforces senior staff with two new execs
February 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi
Sanofi has reinforced its senior staff with a double-whammy of appointments; firstly, the French firm has announced that it is …
Sanofi & Regeneron’s arthritis drug scores first approval following FDA rejection
February 1, 2017Research and Development, Sales and Marketing Actemra, Humira, Kevzara, Regeneron, Roche, Sanofi, sarilumab
Kevzara (sarilumab), a interleukin-6 (IL06) receptor antibody developed by Sanofi and Regeneron and the first real competitor to Roche’s Actemra …
Price-fixing class action lawsuit levelled at three major insulin producers
January 31, 2017Manufacturing and Production, Sales and Marketing Eli Lilly, Novo Nordisk, Sanofi, diabetes, insulin, price-fixing
A group of patients has filed a class action lawsuit in a federal court in Massachusetts, accusing three companies of …
Sanofi announces new VP of External Affairs
January 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi
Kathleen Tregoning has been announced as Sanofi’s vice president of External Affairs and as a new member of the Executive …
Five most talked about mergers and acquisitions of 2016
January 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Bayer, Boehringer, Johnson & Johnson, Sanofi, Teva, acquisition, mergers, monsanto, pharma
2017 has kicked off with a bang – as Johnson & Johnson confirmed a $30 billion deal to takeover of …
Sanofi diabetes drug Sulinqua green-lighted in Europe
January 19, 2017Research and Development, Sales and Marketing Sanofi, Sulinqua
Sanofi’s diabetes drug Suliqua has been granted marketing authorisation by the European Commission, giving the go ahead for the launch …
22 pharma companies join forces for global non-communicable disease initiative
January 18, 2017Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda
The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …
Philippine FDA orders Sanofi to pull dengue vaccine ads
January 5, 2017Medical Communications, Sales and Marketing Philippines, Sanofi, Vaccine, dengue, virus
Sanofi has suffered a major blow to its dengue immunisation programme in the Philippines after it was requested the company …
Amgen’s patent win upheld against Sanofi-Regeneron
January 4, 2017Medical Communications, Research and Development Amgen, Regeneron, Sanofi, patent
In March 2016, Amgen won two major patent cases against Sanofi and Regeneron over their drug, Praleunt, after it was …
Sanofi and MSD end their joint vaccines partnership
January 3, 2017Research and Development MSD, Sanofi, Sanofi pasteur msd
With a new year comes a fresh start, and so it was the case with Sanofi and MSD’s joint vaccine …
Sanofi files lawsuit against Novo Nordisk over ‘false allegations’
January 3, 2017Manufacturing and Production, Sales and Marketing Novo Nordisk, Sanofi
Sanofi has sued Novo Nordisk over claims made in an advertising campaign for its drug Tresiba. Sanofi has filed the …
Sanofi and Boehringer confirm successful exchange of businesses
January 3, 2017Manufacturing and Production, Sales and Marketing Boehringer Ingelheim, Sanofi
Sanofi and Boehringer Ingelheim have confirmed the successful completion of the exchange of Sanofi’s animal health business (Merial, based in …
Actelion acquisition hokey-cokey continues with J&J returning to table
December 22, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi
The Actelion takeover saga continues with Johnson & Johnson back in the game, and now re-entering into exclusive negotiations. Actelion …
Latest content
Five Facts about cardiovascular disease
